J Dumont

787 total citations
35 papers, 595 citations indexed

About

J Dumont is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J Dumont has authored 35 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 14 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J Dumont's work include Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Lung Cancer Treatments and Mutations (6 papers). J Dumont is often cited by papers focused on Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Lung Cancer Treatments and Mutations (6 papers). J Dumont collaborates with scholars based in France, Canada and United States. J Dumont's co-authors include Brigitte Bauvois, Claire Mathiot, J.P. Kolb, Mojgan Djavaheri‐Mergny, Jerzy Klijanienko, Philippe Vielh, Dany Rouillard, Juana Wietzerbin, F Teillet and Paul Neve and has published in prestigious journals such as The Lancet, Oncogene and British Journal of Cancer.

In The Last Decade

J Dumont

31 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Dumont France 12 224 207 151 145 95 35 595
J.‐P. Magaud France 12 213 1.0× 348 1.7× 252 1.7× 167 1.2× 180 1.9× 24 845
T Flores Spain 9 228 1.0× 126 0.6× 232 1.5× 112 0.8× 50 0.5× 21 570
Takashi Akasaka Japan 15 194 0.9× 323 1.6× 222 1.5× 229 1.6× 120 1.3× 45 660
AS Asch United States 9 428 1.9× 125 0.6× 259 1.7× 146 1.0× 138 1.5× 10 1.0k
Sakura Sakajiri Japan 14 272 1.2× 194 0.9× 358 2.4× 106 0.7× 110 1.2× 32 704
Giovanni Citterio Italy 15 339 1.5× 193 0.9× 251 1.7× 117 0.8× 216 2.3× 37 853
C Lavignac France 8 369 1.6× 504 2.4× 260 1.7× 249 1.7× 134 1.4× 14 836
A Rosolen Italy 19 263 1.2× 317 1.5× 366 2.4× 87 0.6× 252 2.7× 45 956
Thomas A. Summers United States 12 321 1.4× 186 0.9× 131 0.9× 89 0.6× 53 0.6× 32 566
Sergei Syrbu United States 16 399 1.8× 544 2.6× 173 1.1× 259 1.8× 149 1.6× 66 910

Countries citing papers authored by J Dumont

Since Specialization
Citations

This map shows the geographic impact of J Dumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Dumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Dumont more than expected).

Fields of papers citing papers by J Dumont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Dumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Dumont. The network helps show where J Dumont may publish in the future.

Co-authorship network of co-authors of J Dumont

This figure shows the co-authorship network connecting the top 25 collaborators of J Dumont. A scholar is included among the top collaborators of J Dumont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Dumont. J Dumont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dumont, J, Céline Mascaux, Pierre‐Emmanuel Falcoz, et al.. (2024). Impact of adjuvant radiotherapy and chemotherapy on thymoma. Cancer/Radiothérapie. 28(2). 174–181.
2.
Mathiot, Claire, Didier Decaudin, Jerzy Klijanienko, et al.. (2006). Fine-needle aspiration cytology combined with flow cytometry immunophenotyping is a rapid and accurate approach for the evaluation of suspicious superficial lymphoid lesions. Diagnostic Cytopathology. 34(7). 472–478. 28 indexed citations
3.
Bauvois, Brigitte, J Dumont, Claire Mathiot, & J.P. Kolb. (2002). Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons. Leukemia. 16(5). 791–798. 88 indexed citations
4.
Decaudin, Didier, Jozo Delić, J Dumont, et al.. (2002). Clinical Efficacy of Irradiation in CLL Patients: Predictive Value of in Vitro Radio-induced Apoptosis. Leukemia & lymphoma. 43(4). 827–829. 3 indexed citations
5.
Ramaioli, A., C Théodore, M.-J. Terrier-Lacombe, et al.. (2001). Non-Hodgkin’s lymphoma of the testis: A retrospective study of 84 patients treated in the French anticancer centres. Annals of Oncology. 12(9). 1313–1315. 44 indexed citations
6.
Bauvois, Brigitte, Mojgan Djavaheri‐Mergny, Dany Rouillard, J Dumont, & Juana Wietzerbin. (2000). Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cells. Oncogene. 19(2). 265–272. 67 indexed citations
7.
Dubray, Bernard, Jozo Delić, Jerzy Klijanienko, et al.. (1998). In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in non-Hodgkin's lymphomas. Radiotherapy and Oncology. 46(2). 185–191. 62 indexed citations
8.
Maciorowski, Zofia, Jozo Delić, Jerzy Klijanienko, et al.. (1998). Comparative analysis of apoptosis measured by Hoechst and flow cytometry in non-Hodgkin's lymphomas. Cytometry. 32(1). 44–50. 26 indexed citations
9.
Dumont, J, et al.. (1992). [Large cell lymphomas: effect of histologic groups on the prognosis. Study of 210 cases treated with the same therapeutic protocols].. PubMed. 40(2-3). 110–5. 1 indexed citations
10.
Dumont, J, Véronique Mosseri, Jean Gabarre, et al.. (1991). Multicentre combined chemotherapy protocol for large cell advanced non hodgkin's lymphoma. Hematological Oncology. 9(4-5). 197–207. 3 indexed citations
11.
Philip, Thierry, J Dumont, F Teillet, et al.. (1986). High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease. British Journal of Cancer. 53(6). 737–742. 60 indexed citations
12.
Troussard, Xavier, M Leporrier, C. Lacombe, et al.. (1985). [Chronic lymphocytic leukemia, erythroblastopenia, thymolipoma].. PubMed. 27(1). 29–37. 2 indexed citations
13.
Aurias, Alain, J Dumont, A Mazabraud, & G Lenoir. (1985). Immunoblastic lymphoma following Hodgkin's disease: A case report with translocation t(8;14) in tumoral cells and sporadic t(7;14) in peripheral lymphocytes. Cancer Genetics and Cytogenetics. 18(1). 55–63. 2 indexed citations
14.
Jl, Harousseau, et al.. (1980). [Acute myeloblastic leukaemia in the course of non-Hodgkin's lymphoma (author's transl)].. PubMed. 9(46). 3513–6. 1 indexed citations
15.
Dumont, J, et al.. (1980). Acute myeloid leukemia following non-Hodgkin's lymphoma: danger of prolonged use of chlorambucil as maintenance therapy.. PubMed. 22(4). 391–404. 4 indexed citations
16.
Dumont, J, et al.. (1979). [Comparative study of anti EBV antibodies in non-Hodgkin's lymphomams and angio-immunoblastic lymphadenopathies (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 66(4). 373–81. 2 indexed citations
17.
Dumont, J & A Mazabraud. (1979). Primary lymphomas of bone (so-called ("Parker and Jackson's reticulum cell sarcoma") : histological review of 75 cases according to the new classifications of non Hodgkin's lymphomas.. PubMed. 31(9-10). 271–5. 12 indexed citations
18.
Liabeuf, A., N Feingold, F. M. Kourilsky, J Dumont, & Werner Henle. (1976). Anti‐ebv antibody titers in non‐hodgkin lymphomas. International Journal of Cancer. 18(1). 14–23. 12 indexed citations
19.
Dumont, J, et al.. (1975). [Survival time study of lympho- and reticulosarcomas as a function of various clinical and histological factors].. PubMed. 61(1). 51–60. 1 indexed citations
20.
Neve, Paul & J Dumont. (1970). Effects in vitro of thyrotropin, cyclic 3?,5?-AMP, dibutyryl cyclic 3?,5?-AMP, and prostaglandin E on the ultrastructure of dog thyroid slices. Experimental Cell Research. 63(2-3). 285–292. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.‐P. Magaud Breakdown of academic impact, for papers by T Flores Breakdown of academic impact, for papers by Takashi Akasaka Breakdown of academic impact, for papers by AS Asch Breakdown of academic impact, for papers by Sakura Sakajiri Breakdown of academic impact, for papers by Giovanni Citterio Breakdown of academic impact, for papers by C Lavignac Breakdown of academic impact, for papers by A Rosolen Breakdown of academic impact, for papers by Thomas A. Summers Breakdown of academic impact, for papers by Sergei Syrbu
Rankless by CCL
2026